The testing kit is intended for isolation of DNA/RNA from human clinical material by the method based on magnetic particles for subsequent PCR testing.
The kit is designed to detect polymorphisms associated with drug resistance to second-line chemotherapy drugs (aminoglycosides and fluoroquinolones) and their analogues. The result of the assay makes it possible to choose the appropriate therapy for patients with a confirmed diagnosis of pulmonary and extrapulmonary tuberculosis.
The kit is designed for detection of the tuberculosis and non-tuberculosis complex mycobacteria and their differentiation in patients with suspected pulmonary and extrapulmonary tuberculosis, mycobacteriosis.
The kit is designed for qualitative and quantitative detection of human herpes simplex virus type 6 (HHV-6) DNA. It is used when examining patients with suspected herpes simplex virus infection and a confirmed diagnosis to assess viral load and evaluate the effectiveness of treatment.
The kit is designed for detection and differentiation of human immunodeficiency viruses type 1 and 2 (HIV-1 and HIV-2) in order to diagnose the HIV infection and choose an antiretroviral therapy regimen.